✦ LIBER ✦

Use of Infliximab, an Anti-Tumor Necrosis Alpha Antibody, for Inflammatory Dermatoses

✍ Scribed by Anna Drosou; RobertS. Kirsner; Esperanza Welsh; ToryP. Sullivan; FranciscoA. Kerdel

Book ID: 106297956
Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 77 KB
Volume: 7
Category: Article
ISSN: 1203-4754
DOI: 10.1007/s10227-002-0134-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Inflammatory Bowel Disease

Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies

✍ Magro, Fernando; Portela, Francisco 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 290 KB

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha

A controlled trial of anti-tumor necrosi

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease

✍ WJ Sandborn 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Successful use of an anti-tumor necrosis

Successful use of an anti-tumor necrosis factor-alpha (TNF-α) monoclonal antibody (infliximab) for the treatment of cytomegalovirus (CMV)–induced pneumonitis after allogeneic haemopoietic stem cell transplantation (allo-HSCT)

✍ C.A. Garcı́a Sepúlveda; R. Ovilla Martı́nez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Tumor Necrosis Factor-Alpha Binding Capa

Tumor Necrosis Factor-Alpha Binding Capacity and Anti-Infliximab Antibodies Measured by Fluid-Phase Radioimmunoassays as Predictors of Clinical Efficacy of Infliximab in Crohn's Disease

✍ Ainsworth, Mark A.; Bendtzen, Klaus; Brynskov, Jørn 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 199 KB

Development of interstitial pneumonia in

Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Mineharu Sugimoto 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 326 KB